Patent ID: 11707453

Abstract:
The invention relates to the treatment or control of unipolar depressive disorder by administering a compound of Formula I or a salt thereof to a subject; wherein:  E is S or Se;  R1 and R2 are optional substituents, and are at each occurrence independently selected from:  (1) a halogen, which is preferably selected from F, Cl and Br;  (2) C1-C4 alkyl, such as C1-C2 alkyl or C1 alkyl, optionally substituted with one or more halogen atoms, each of which is preferably selected from F, Cl and Br; and  (3) C1-C4 alkoxy, such as C1-C2 alkoxy or C1 alkoxy; optionally substituted with one or more halogen atoms, each of which is preferably selected from F, Cl and Br;  m is an integer in the range of from 0 to 5; and  n is an integer in the range of from 0 to 4.